Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon beta normalizes suppressor cell function in dysimmune neuropathies

Giovanna De Luca1, Alessandra Lugaresi1, Carla Iarlori1

  • 1Center for Neuromuscular Diseases, Department of Oncology and Neurosciences of the University of Chieti, Policlinico Clinicizzato `Colle Dell'Ara', I-66013 Chieti, Italy.

Journal of Neuroimmunology
|April 4, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

The journal of headache and pain·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Neurology and therapy·2026
Same author

Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.

Journal of neurology·2026
Same author

Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Journal of neurology·2026

Defective suppressor cell function is implicated in chronic inflammatory demyelinating polyneuropathy (CIDP) and paraproteinemic neuropathy. Interferon beta normalized this function, suggesting its potential as an adjunctive therapy for CIDP.

Area of Science:

  • Neuroimmunology
  • Neurology

Background:

  • Idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP) and paraproteinemic neuropathy are dysimmune neuropathies.
  • Suppressor cell dysfunction is a potential factor in these conditions.

Purpose of the Study:

  • To investigate suppressor cell function in CIDP and paraproteinemic neuropathy.
  • To evaluate the effect of interferon beta on suppressor cell function in these neuropathies.

Main Methods:

  • In vitro analysis of suppressor cell function.
  • Assessment of suppressor cell function in the presence of interferon beta.

Main Results:

  • A defect in suppressor cell function was identified in both idiopathic CIDP and paraproteinemic neuropathy.

Related Experiment Videos

  • Interferon beta treatment normalized suppressor cell function in vitro.

    • Conclusions:

    • Decreased suppressor cell function plays a role in the pathogenesis of dysimmune neuropathies.
    • Interferon beta may serve as an adjunctive therapy for CIDP by improving blood-nerve barrier function and normalizing suppressor cell activity.